Each year, the FDA approves a wide range of medications that help shape the future of medicine in the U.S. These include ...

Shares in nuclear medicine play Clarity Pharmaceuticals have surged up to 12% after the company's swift and supersized $203 ...

FDA issued CRLs for RP1 and glofitamab; CB-010 shows promise in lymphoma; osimertinib plus chemo extends NSCLC survival; and ...